SURE CLINIC LTD

Company number 08864521 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: B-

Explanation: SURE CLINIC LTD is a recovering patient showing strong signs of renewed vitality, but it carries an underlying condition that makes it vulnerable to external shocks. The business has successfully returned to profitability and is rebuilding its equity base after a period of significant financial distress. However, its working capital pulse is heavily dependent on a related party, meaning its financial immunity is compromised. If the wider "family" of companies catches a cold, this business could quickly develop pneumonia.


1. Key Vital Signs

  • Heart Rate (Cash Position): Improving but still erratic. Cash at bank surged from a dangerously low £1,211 in 2024 to a healthier £11,435 in 2025. While this is a positive rebound—a strengthening pulse—it remains well below the £29k-£35k cash reserves maintained between 2017-2019, indicating the business is still not generating the same level of liquid reserves.
  • Blood Pressure (Liquidity Ratio): Elevated but artificially supported. Net Current Assets (working capital) stand at £36,767, giving a current ratio of approximately 2.2:1 (Current Assets £66,687 / Current Liabilities £29,920). On the surface, this looks like excellent blood pressure—easily able to cover short-term debts. However, this is heavily reliant on £54,252 owed by group undertakings.
  • BMI (Leverage/Solvency): Healthy weight. Total liabilities (£52,036) are well covered by total assets (£96,641). The business has a solid equity base of £44,605, meaning it is not over-leveraged or "obese" with debt.
  • White Blood Cell Count (Profitability): Fighting fit. Net assets grew from £34,426 to £44,605—an increase of £10,179. The Profit and Loss reserve also grew by the same amount, confirming the business is generating healthy organic margins once again.

2. Symptoms Analysis

  • The Group Dependency (Autoimmune Vulnerability): The most critical symptom in these accounts is that virtually all debtors (£54,252 out of £54,252) are "Amounts owed by group undertakings." The business is controlled by Trent View Holdings Ltd, and it appears Sure Clinic is acting as a financing vehicle or centralised cash pool for the group. While this internal money flow keeps the liquidity ratio looking healthy, it means Sure Clinic has no independent trade debtors. If the group entities fail to settle their inter-company balances, Sure Clinic’s working capital would instantly haemorrhage, leaving it unable to pay its £29,920 in current liabilities.
  • The Historical Blip (Previous Cardiac Arrest): Looking at the 10-year history, the business had a major health scare around 2020-2022. Net assets flatlined to just £5,063 in 2022 (down from £72,942 in 2018), while total liabilities ballooned. The fact that the business has recovered to £44,605 in net assets is commendable, but the memory of that sharp drop suggests the business model is susceptible to sudden shocks.
  • Taxation Strain: The business owes £24,391 in taxation and social security. This is a significant chunk of its current liabilities and suggests that the recent profitability has created a tax liability that will need careful cash flow management to settle.

3. Diagnosis

Recovering Condition with Compromised Circulatory Autonomy

The patient has made a remarkable recovery from the financial malaise of 2021/22. The return to profitability and the rebuilding of the P&L reserve show that the core business (gait and posture clinic/manufacturing orthotics) has a solid heartbeat.

However, the business suffers from "circulatory dependency." Because it is owed over £54k by its parent/sibling companies, its apparent financial health is an illusion of group accounting. The business does not have control over its own cash flow destiny; it is at the mercy of Trent View Holdings Ltd. Should the group decide to delay payment, Sure Clinic would rapidly become illiquid despite being fundamentally profitable. Furthermore, the lack of an audit (taking advantage of the small companies exemption) means there is no independent medical examiner verifying the recoverability of these group debts.


4. Recommendations

  1. Improve Circulatory Independence: Negotiate formal terms with group undertakings to ensure the £54,252 inter-company debt is settled on a regular, commercial basis. This will boost independent cash reserves and reduce reliance on the parent company for day-to-day liquidity.
  2. Cash Resuscitation Plan: While cash has improved, the business should aim to rebuild its reserves to pre-2020 levels (around £30k) to ensure it has a sufficient "immune system" to weather future economic illnesses without requiring group intervention.
  3. Monitor the Tax Pulse: With a £24,391 tax liability due within the year, the business must ensure it has a dedicated cash reserve or payment plan in place to meet this obligation without needing to call in the group debtor balance.
  4. Long-term Health Check: Continue the current trajectory of profitable trading. The reduction in long-term bank loans from £26,790 to £22,116 shows the business is slowly paying down its chronic debt, which is an excellent habit for long-term financial wellness.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 11 September 2026